Want to see BLMH full AI Analyst Report?
Blum Holdings (BLMH) AI Stock Analysis
Blum Holdings
(Other OTC:BLMH)
The stock is under severe pressure, driven primarily by a financially distressed and insolvent balance sheet, persistent cash burn, and deeply negative profitability. Technical trends reinforce this weakness, with the price trading below all major moving averages. The negative P/E ratio further confirms the lack of earnings power, leaving no fundamental or technical support for the shares.
Blum Holdings (BLMH) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $2.70M
- Dividend Yield
- ―
- Average Volume (3M)
- 4,474
- Price to Earnings (P/E)
- -0.6
- Beta (1Y)
- 2.31
- Revenue Growth
- 19.98%
- EPS Growth
- -180.06%
- Country
- US
- Employees
- 133
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Specialty Retail
Blum Holdings Business Overview & Revenue Model
Company Description
Blum Holdings, Inc. is an entity operating within California's regulated cannabis market, comprehensively addressing both medical and adult-use demands. The company's multifaceted involvement encompasses the cultivation, production, distribution, and...
Blum Holdings Financial Statement Overview
Summary
Financial health is critically weak. The company is technically insolvent with negative equity, persistent operating losses, and deeply negative margins. Cash flow from operations has been negative for five consecutive periods, indicating the core business is not self-sustaining.
Income Statement
18Very NegativeBalance Sheet
8Very NegativeCash Flow
15Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Mar 2024 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.76M | 14.91M | 12.99M | 33.23M | 52.02M | 42.12M |
| Gross Profit | 6.59M | 6.00M | 6.21M | 14.00M | 16.90M | 11.02M |
| EBITDA | -6.31M | -6.30M | 22.00M | -2.26M | -180.51M | -30.07M |
| Net Income | -9.39M | -7.96M | 33.10M | -14.13M | -188.93M | -31.27M |
Balance Sheet | ||||||
| Total Assets | 43.57M | 44.52M | 24.82M | 32.07M | 40.51M | 271.82M |
| Cash, Cash Equivalents and Short-Term Investments | 590.00K | 813.00K | 1.04M | 862.00K | 1.20M | 6.70M |
| Total Debt | 7.94M | 7.50M | 4.79M | 37.70M | 49.56M | 79.41M |
| Total Liabilities | 51.67M | 48.74M | 29.56M | 77.77M | 77.05M | 125.34M |
| Stockholders Equity | -11.05M | -7.17M | -6.75M | -45.70M | -36.54M | 142.63M |
Cash Flow | ||||||
| Free Cash Flow | -2.45M | -2.53M | -2.15M | -1.29M | -9.76M | -21.93M |
| Operating Cash Flow | -2.43M | -2.50M | -2.14M | -965.00K | -7.83M | -17.96M |
| Investing Cash Flow | 65.00K | -971.00K | 2.03M | 462.00K | 19.61M | 21.67M |
| Financing Cash Flow | 2.59M | 3.25M | 143.00K | 539.00K | -17.27M | 4.50M |
Blum Holdings Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BLMH, the sentiment is Positive. The current price of 0.15 is below the 20-day moving average (MA) of 0.18, below the 50-day MA of 0.19, and below the 200-day MA of 0.24, indicating a neutral trend. The MACD of -0.01 indicates Negative momentum. The RSI at 55.49 is Neutral, neither overbought nor oversold. The STOCH value of 41.20 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BLMH.
Blum Holdings Risk Analysis
Blum Holdings disclosed 56 risk factors in its most recent earnings report. Blum Holdings reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksBlum Holdings Peers Comparison
Overall Rating
AYTU62Neutral
YCBD43Neutral
SNOA42Neutral- BLMH38Underperform
PRFX38Underperform
IMCC37Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| AYTU | 62Neutral | $20.98M | -1.42 | -52.89% | ― | -13.27% | 27.11% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| YCBD | 43Neutral | $4.29M | -1.29 | -34.25% | ― | 10.01% | 95.01% |
| SNOA | 42Neutral | $5.27M | -0.90 | -53.56% | ― | 47.00% | 50.49% |
| BLMH | 38Underperform | $4.95M | -0.56 | 107.69% | ― | 19.98% | -180.06% |
| PRFX | 38Underperform | $2.22M | -0.07 | -72.87% | ― | ― | ― |
| IMCC | 37Underperform | $1.30M | -0.03 | 841.81% | ― | -11.91% | -285.26% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| BLMH | Blum Holdings Inc | 0.20 | -0.46 | -69.80% | |
| SNOA | Sonoma Pharmaceuticals, Inc. | 1.10 | -2.66 | -70.74% | |
| AYTU | Aytu BioScience | 1.94 | -0.19 | -8.92% | |
| YCBD | Cbdmd INc | 0.40 | -0.41 | -51.11% | |
| PRFX | Painreform Ltd. | 0.75 | -4.50 | -85.71% | |
| IMCC | Im Cannabis Corp | 0.75 | -37.65 | -98.05% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 24, 2026